参考文献/References:
[1]中华医学会神经外科学分会,国家卫健委脑卒中筛查与防治工程委员会,海峡两岸医药卫生交流协会神经外科分会缺血性脑血管病学组.大面积脑梗死外科治疗指南[J].中华医学杂志,2021,101(45):3700-3711.[2]邹蔷薇,王惠婕,何欣,等.局部亚低温联合丁苯酞注射液治疗对急性脑梗死患者细胞凋亡及斑块稳定性的影响[J].疑难病杂志,2019,18(11):1099-1102,1107.[3]李霜梅,蔡娟,石小晶,等.丁苯酞软胶囊联合阿托伐他汀钙片对脑梗死病人侧支循环建立的影响[J].中西医结合心脑血管病杂志,2017,15(1):103-105.[4]张剑,刘芳怡,陈源,等.丁苯酞序贯联合常规用药治疗脑梗死合并颈内动脉中重度狭窄患者的临床研究[J].中国临床药理学杂志,2021,37(14):1851-1854.[5]牛亚妹,刘丽.阿加曲班联合丁苯酞治疗急性脑梗死临床评价[J].中国药业,2020,29(20):86-88.[6]蒙医康复临床实践指南·脑梗死制定工作组,乌兰图雅,辛浩,等.蒙医康复临床实践指南·脑梗死[J].康复学报,2021,31(4):271-278.[7]Lin B,Wang C,Lu N,et al.Reversible cerebral vasoconstriction syndrome with cerebral infarction caused by acute high-level vapor exposure of ethylene oxide: a case report[J].BMC Neurol,2021,21(1):391.[8]宋祺,孙西庆.红花黄色素注射液联合丁苯酞氯化钠注射液治疗急性脑梗死的效果观察[J].山东医药,2021,61(13):72-75.[9]叶佳媚,林青,彭飞飞.丁苯酞注射液联合双重抗血小板对急性进展性脑梗死的疗效及其机制探讨[J].中国现代医学杂志,2021,31(9):60-66.[10]杨蓉,李寅珍,严首春.丁苯酞氯化钠注射液联合rt-PA超时间窗溶栓治疗急性脑梗死患者的效果评价[J].中国中西医结合急救杂志,2021,28(3):316-319.[11]刘迪 ,朱秋红,郭宏伟,等.丁苯酞氯化钠注射液治疗超静脉溶栓时间窗急性脑梗死的疗效观察[J].中国实用神经疾病杂志,2021,24(6):511-515.[12]Wang H,Lu H,Zhang XM,et al.Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction[J].BMC Neurol,2021,21(1):274.[13]马红彦,刘翠青,李桂德,等.丁苯酞注射液联合阿替普酶静脉溶栓治疗急性脑梗死疗效及对IGF-1、CRP、BNP水平的影响[J].现代中西医结合杂志,2021,30(25):2796-2799.[14]石小晶,李秀敏,杨文军,等.丁苯酞注射液联合银杏二萜内酯注射液对急性脑梗死患者的疗效及侧支循环的改善作用[J].河北医药,2021,43(19):2965-2968.[15]Wang W,Wang S,Zhang K,et al.Hypothyroidism is associated with clinical outcomes in patients with acute myocardial infarction: subgroup analysis of China PEACE study[J].Endocrine,2021,74(1):128-137.[16]Suzuki ARCSY,Tsubakino S,Fujii H.Motor Function and Activities of Daily Living Recovery after Cardiogenic Internal Carotid Artery Infarction:A Retrospective Cohort study[J].J Stroke Cerebrovasc Dis,2021,30(6):105734.[17]陈萍.脑心通胶囊联合丁苯酞注射液治疗急性脑梗死的疗效观察及对血清炎性因子、氧化应激反应、血液流变学的影响[J].中国基层医药,2021,28(10):1516-1520.[18]Liu M,Pu Y,Gu J,et al.Evaluation of Zhilong Huoxue Tongyu capsule in the treatment of acute cerebral infarction: A systematic review and meta-analysis of randomized controlled trials[J].Phytomedicine,2021,86:153566.[19]王琴,孔伟丽,吕康,等.氯吡格雷联合丁苯酞注射液治疗急性脑梗死的效果及对抗氧化能力的影响[J].临床误诊误治,2021,34(4):39-43.[20]余芬.丁苯酞注射液联合丹红注射液治疗急性脑梗死60例[J].中国新药杂志,2018,27(24):2901-2904.[21]汪传香,丁砚兵.丁苯酞氯化钠注射液治疗急性缺血性脑梗死的疗效观察[J].现代药物与临床,2017,32(9):1655-1659.[22]唐娟娟,余朝萍.丁苯酞注射液联合对症治疗对OCSP分型急性脑梗死患者血清IMA、LP-PLA2水平的影响[J].中国急救复苏与灾害医学杂志,2021,16(5):509-512.[23]张东风.丁苯酞联合阿托伐他汀对急性脑梗死患者血流动力学及血清SOD、GSH-Px、NO水平的影响[J].临床药物治疗杂志,2018,16(3):37-41.[24]姜永宁.丁苯酞联合阿托伐他汀治疗对急性脑梗死患者血清SOD、GSH-Px、NO水平的影响[J].内科急危重症杂志,2018,24(3):206-209.
相似文献/References:
[1]冯 湧.新一代抗凝血药阿加曲班的临床应用进展[J].医学信息,2018,31(02):43.[doi:10.3969/j.issn.1006-1959.2018.02.015]
FENG Yong.Progress in Clinical Application of the New Generation Anticoagulant Agatripine[J].Journal of Medical Information,2018,31(20):43.[doi:10.3969/j.issn.1006-1959.2018.02.015]
[2]陈建新.阿加曲班注射液治疗急性脑梗死的疗效及对血清VEGF、GLUT-1水平的影响[J].医学信息,2018,31(19):5.[doi:10.3969/j.issn.1006-1959.2018.19.002]
CHEN Jian-xin.Effect of Argatroban Injection on Acute Cerebral Infarction and Its Effect on Serum VEGF and GLUT-1 Levels[J].Journal of Medical Information,2018,31(20):5.[doi:10.3969/j.issn.1006-1959.2018.19.002]
[3]刘 然.头颅MRI-DWI病灶数量及部位对脑梗死复发预测意义[J].医学信息,2018,31(22):172.[doi:10.3969/j.issn.1006-1959.2018.22.052]
LIU Ran.The Significance of the Number and Location of MRI-DWI Lesions in Predicting the Recurrence of Cerebral Infarction[J].Journal of Medical Information,2018,31(20):172.[doi:10.3969/j.issn.1006-1959.2018.22.052]
[4]徐润鸿.血府逐瘀汤联合阿托伐他汀钙治疗急性脑梗死的临床观察[J].医学信息,2019,32(05):165.[doi:10.3969/j.issn.1006-1959.2019.05.054]
XU Run-hong.Clinical Observation on Treatment of Acute Cerebral Infarction with Xuefu Zhuyu Decoction Combined with Atorvastatin Calcium[J].Journal of Medical Information,2019,32(20):165.[doi:10.3969/j.issn.1006-1959.2019.05.054]
[5]赵宏伟.急性脑梗死的危险因素及临床诊治研究[J].医学信息,2019,32(18):44.[doi:10.3969/j.issn.1006-1959.2019.17.015]
ZHAO Hong-wei.Risk Factors and Clinical Diagnosis and Treatment of Acute Cerebral Infarction[J].Journal of Medical Information,2019,32(20):44.[doi:10.3969/j.issn.1006-1959.2019.17.015]
[6]陶 林,马 婷.丁苯酞注射液、胶囊序贯疗法辅治急性进展性脑梗死的
疗效及其对神经功能的影响[J].医学信息,2019,32(18):135.[doi:10.3969/j.issn.1006-1959.2019.18.045]
TAO Lin,MA Ting.Efficacy of Butylphthalide Injection and Capsule Sequential Therapy in the Treatment of Acute Progressive Cerebral Infarction and Its Effect on Neurological Function[J].Journal of Medical Information,2019,32(20):135.[doi:10.3969/j.issn.1006-1959.2019.18.045]
[7]朱丽娜,王宗立,顾萌萌.UA、Hcy和FIB与颈动脉粥样硬化斑块及
脑梗死关系的分析[J].医学信息,2019,32(18):173.[doi:10.3969/j.issn.1006-1959.2019.18.061]
ZHU Li-na,WANG Zong-li,GU Meng-meng.Analysis of the Relationship Among UA, Hcy,FIB and Carotid Atherosclerotic Plaque,
Cerebral Infarction[J].Journal of Medical Information,2019,32(20):173.[doi:10.3969/j.issn.1006-1959.2019.18.061]
[8]王丹丹,王学建.动脉自旋标记在急性脑梗死中的应用[J].医学信息,2019,32(12):102.[doi:10.3969/j.issn.1006-1959.2019.12.031]
WANG Dan-dan,WANG Xue-jian.Application of Arterial Spin Labeling in Acute Cerebral Infarction[J].Journal of Medical Information,2019,32(20):102.[doi:10.3969/j.issn.1006-1959.2019.12.031]
[9]陈 曦,刘 楠,张洪淞.尤瑞克林治疗急性脑梗死患者的临床效果[J].医学信息,2019,32(12):156.[doi:10.3969/j.issn.1006-1959.2019.12.052]
CHEN Xi,LIU Nan,ZHANG Hong-song.Clinical Effect of Ureklin in Patients with Acute Cerebral Infarction[J].Journal of Medical Information,2019,32(20):156.[doi:10.3969/j.issn.1006-1959.2019.12.052]
[10]陈 曦,刘 楠,张洪淞.马来酸桂哌齐特联合尤瑞克林在急性脑梗死患者中的疗效[J].医学信息,2019,32(14):142.[doi:10.3969/j.issn.1006-1959.2019.14.046]
CHEN Xi,LIU Nan,ZHANG Hong-song.Efficacy of Cinepazide Maleate Combined with Uricillin in Patients with Acute Cerebral Infarction[J].Journal of Medical Information,2019,32(20):142.[doi:10.3969/j.issn.1006-1959.2019.14.046]